David Einhorn’s Tenet Healthcare Corp (THC) position
Reported position history, portfolio importance and verified filing changes from public SEC disclosures.
At a glance
The full verified relationship, including prior ownership episodes and exits where supported.
DME Capital Management first reported Tenet Healthcare Corp in Q1 2024. The reported position was reduced across later filings. The latest verified relationship event shows that DME Capital Management sold the entire position in Q4 2024, and the stock is no longer reported in the latest verified portfolio.
Position over time
See the same verified relationship through reported shares, portfolio weight or reported value.
Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.
What changed
Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.
Filing context
Quarter-end price $166.20 · Estimated holding basis $105.11
Filing context
Quarter-end price $133.03 · Estimated holding basis $105.11
How important was Tenet Healthcare Corp in DME Capital Management’s reported portfolio?
Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.
Who else owns Tenet Healthcare Corp?
Also reported by 2 other tracked investors in their latest verified filings.
SEC filing evidence
Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.
Market context only; not an investor transaction price.
SEC history uses the documented manager succession from Greenlight Capital Inc. to DME Capital Management, LP. This tracker reflects public Form 13F disclosures, not David Einhorn’s personal brokerage account or exact trade dates.